Cyril Amarchand Mangaldas assisted Zenex with legal due diligence, drafting and negotiation of the transaction documents associated with the acquisition of 100% stake in Ayurvet.
The General Corporate, Real Estate and Finance teams of Cyril Amarchand Mangaldas advised on the transaction.
The transaction team was led by Ravi Shah, Partner; with support from Bhakti Madan, Senior Associate; and Dhwani Shah, Associate.
The team led by Ashish Jain, Partner; with support from Karan Sharma, Principal Associate; Siddhant Sharma, Senior Associate; and Ena Kapur, Associate, advised on real estate related aspects of the transaction.
Lakshmi Prakash, Partner with support from Krithika Srinivasan, Associate, advised on the financing related aspects of the transaction.
Other advisors to the transaction included Juris Legal (acted as legal counsel for Ayurvet).
The transaction was closed on 14th December 2023.
____________________________________________
About Cyril Amarchand Mangaldas
Cyril Amarchand Mangaldas (cam) is India’s leading law firm with a global reputation of being trusted advisers to its clients. The Firm advises a large and diverse set of clients, including domestic and foreign commercial enterprises, financial institutions, private equity and venture capital funds, start-ups, government and regulatory bodies. The Firm generalists, specialists and senior ex-regulators expertly guide clients across a spectrum of transactions, sectors and regulations. The Firm is one of the largest full-service law firm in India and offices in key business centers at Mumbai, Delhi-NCR, Bengaluru, Ahmedabad, Hyderabad, Chennai, GIFT City and also in Singapore.
The Firm received “National Law Firm of the Year: India” at the IFLR Asia-Pacific Awards for the second consecutive years in 2023 and 2022 and “Innovation in Advancing Markets” award at the FT Innovative Lawyers Asia Pacific 2022 Awards. The Firm had won “India Deal Firm of the Year” at the ALB India Awards and “Firm of the Year” at the IFLR1000 India Awards in 2022.
